| Dapagliflozin in patients with heart failure and reduced ejection fraction JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ... New England Journal of Medicine 381 (21), 1995-2008, 2019 | 5725 | 2019 |
| HFSA 2010 comprehensive heart failure practice guideline. J Lindenfeld, NM Albert, JP Boehmer, SP Collins, JA Ezekowitz, ... Journal of cardiac failure 16 (6), e1-194, 2010 | 2619* | 2010 |
| Effect of nesiritide in patients with acute decompensated heart failure CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ... New England Journal of Medicine 365 (1), 32-43, 2011 | 1442 | 2011 |
| Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial KE Flynn, IL Piña, DJ Whellan, LI Lin, JA Blumenthal, SJ Ellis, LJ Fine, ... Jama 301 (14), 1451-1459, 2009 | 918 | 2009 |
| 2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure JA Ezekowitz, E O'Meara, MA McDonald, H Abrams, M Chan, ... Canadian Journal of Cardiology 33 (11), 1342-1433, 2017 | 799 | 2017 |
| Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien, ... Canadian Journal of Cardiology 34 (5), 506-525, 2018 | 708 | 2018 |
| HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical … BL Wilkoff, A Auricchio, J Brugada, M Cowie, KA Ellenbogen, AM Gillis, ... Europace 10 (6), 707-725, 2008 | 615 | 2008 |
| Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management JMO Arnold, P Liu, C Demers, P Dorian, N Giannetti, H Haddad, ... Canadian Journal of Cardiology 22 (1), 23-45, 2006 | 579 | 2006 |
| Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of … AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ... Canadian Journal of Cardiology 32 (5), 569-588, 2016 | 542 | 2016 |
| Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ... New England Journal of Medicine 384 (2), 105-116, 2021 | 537 | 2021 |
| The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ... Canadian Journal of Cardiology 31 (5), 549-568, 2015 | 491 | 2015 |
| Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children DM Rabi, KA McBrien, R Sapir-Pichhadze, M Nakhla, SB Ahmed, ... Canadian Journal of Cardiology 36 (5), 596-624, 2020 | 487 | 2020 |
| Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand, J Bělohlávek, ... Jama 323 (14), 1353-1368, 2020 | 465 | 2020 |
| N-terminal pro–B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized … GW Moe, J Howlett, JL Januzzi, H Zowall Circulation 115 (24), 3103-3110, 2007 | 429* | 2007 |
| Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults AA Leung, SS Daskalopoulou, K Dasgupta, K McBrien, S Butalia, ... Canadian Journal of Cardiology 33 (5), 557-576, 2017 | 424 | 2017 |
| The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ... Canadian Journal of Cardiology 30 (5), 485-501, 2014 | 377 | 2014 |
| Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial JA Blumenthal, MA Babyak, C O’Connor, S Keteyian, J Landzberg, ... Jama 308 (5), 465-474, 2012 | 364 | 2012 |
| A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left … JJV McMurray, DL DeMets, SE Inzucchi, L Køber, MN Kosiborod, ... European journal of heart failure 21 (5), 665-675, 2019 | 330 | 2019 |
| The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy DG Hackam, NA Khan, BR Hemmelgarn, SW Rabkin, RM Touyz, ... Canadian Journal of Cardiology 26 (5), 249-258, 2010 | 314 | 2010 |
| The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension DG Hackam, RR Quinn, P Ravani, DM Rabi, K Dasgupta, ... Canadian Journal of Cardiology 29 (5), 528-542, 2013 | 303 | 2013 |
Justin EzekowitzBestätigte E-Mail-Adresse bei ualberta.ca
